PharmaRelations ApS: Financial statements 2018
CVR: 38215663
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PharmaRelations ApS (CVR 38215663) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 5,138,110 and a net result of DKK 488,382. Equity in the 2018 report amounted to DKK 470,410. The solvency ratio was 13%.
- Gross Profit
- DKK 5,138,110
- Profit/Loss
- DKK 488,382
- Equity
- DKK 470,410
- Total Assets
- DKK 3,617,271
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 30, 2018, Lena Birgitta Andersson Hofsberger has left the board of directors of PharmaRelations ApS.
As of November 30, 2018, Fredrik Gunnar Åke Anjou has left the board of directors of PharmaRelations ApS.
As of November 30, 2018, Lena Birgitta Andersson Hofsberger has left the board of directors of PharmaRelations ApS.
As of November 30, 2018, Fredrik Gunnar Åke Anjou has stepped down as director of PharmaRelations ApS.
PharmaRelations ApS has published its interim report for the period November 22, 2016 – December 31, 2017.
About PharmaRelations ApS
PharmaRelations ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Åsa Uppströmer. The company is owned by Kim Raabymagle, Lena Birgitta Andersson Hofsberger and PharmaRelations AB. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 16,777,505 and a net result of DKK -962,688 compared with DKK 253,685 the year before. Equity in the 2025 report amounted to DKK 5,612,668.